Arrowhead Research | ARWR - Creditori Commerciali

Prezzo Delle Azioni
56.72
Cambio Giornaliero
-0.85 -1.48%
Mensile
-11.18%
Annuale
266.65%
Q1 Previsione
53.39




Creditori Commerciali Cambiamento Data
Agios Pharmaceuticals USD 18.36M 1.2M 2025-12
Alnylam Pharmaceuticals USD 115.72M 1.87M 2025-12
Anika Therapeutics USD 4.73M 39K 2025-09
Arrowhead Research USD 32.94M 15.26M 2025-12
Heron Therapeutics USD 8.99M 3.02M 2025-12
Incyte USD 1.63B 1.46B 2025-12
Ionis Pharmaceuticals USD 14.33M 8.47M 2025-09
Ligand Pharmaceuticals USD 3.24M 24.52M 2025-12
Merck USD 4.15B 102M 2025-09
Moderna USD 317M 50M 2025-12
Nektar Therapeutics USD 15.56M 1.28M 2025-09
Novartis USD 4.56B 49M 2025-09
Sarepta Therapeutics USD 280.84M 186.83M 2025-12
TG Therapeutics USD 61.64M 72.38M 2025-09
Ultragenyx Pharmaceutical USD 40.57M 6.33M 2025-09
Vertex Pharmaceuticals USD 3.43B 600.9M 2025-12
Xencor USD 10.83M 1.75M 2025-12